Skip to main content

letter

. 1991 Dec 14;303(6816):1546–1547. doi: 10.1136/bmj.303.6816.1546-a

Coronary heart disease.

J McMurray, H J Dargie

PMCID: PMC1671793 PMID: 1843459

1546

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
Dennis M., Warlow C. Strategy for stroke. BMJ. 1991 Sep 14;303(6803):636–638. doi: 10.1136/bmj.303.6803.636. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kannel W. B., Cupples A. Epidemiology and risk profile of cardiac failure. Cardiovasc Drugs Ther. 1988 Nov;2 (Suppl 1):387–395. [PubMed] [Google Scholar]
Sutton G. C. Epidemiologic aspects of heart failure. Am Heart J. 1990 Dec;120(6 Pt 2):1538–1540. doi: 10.1016/0002-8703(90)90055-3. [DOI] [PubMed] [Google Scholar]
Tunstall-Pedoe H. Coronary heart disease. BMJ. 1991 Sep 21;303(6804):701–704. doi: 10.1136/bmj.303.6804.701. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES